By health condition
By demographic
Each summary is provided by the external research team. The views expressed may not reflect those of the NIHR BioResource.
We’ve also created a few study collections:
Studies 55-63 of 78
Assessment of efficacy and adverse events following SARS-CoV-2 cohort of subjects previously infected with COVID-19
Speciality areaInfection, COVID
Study typeParticipant re-contact
Researcher typeAcademic
Research leadDr James Thaventhiran
Neurological complications of COVID-19 (NeuroCOVID)_CONTROLS
Speciality areaInfection, Neurological Disorders, COVID
Study typeSamples and data
Research leadProfessor David Menon
Post-COVID-19 surveillance: To establish T cell assays for assessing T cell responses and identify individual and immunological factors that account for different disease outcomes
Research leadDr Nyarie Sithole
Healthcare Worker T Cell Recall
Neurological complications of COVID-19 (NeuroCOVID)
COVID-19 Immune Phenotyping Programme (CIPP) and COVID National BioResource.
Research leadProfessor Christoph Hess
INSIGHT: a scalable isothermal NASBA-based platform for COVID-19 diagnosis
Research leadDr Sarah Teichmann
COVID-19 IDentification of Epitopes and Antibodies (COVID-IDEA)
Research leadProfessor Andrew Cope
Research leadProfessor Ken Smith
